News Focus
News Focus
Followers 22
Posts 748
Boards Moderated 0
Alias Born 09/07/2016

Re: BioChica post# 149254

Friday, 10/12/2018 5:01:05 PM

Friday, October 12, 2018 5:01:05 PM

Post# of 448139
Bio- "
Most PCP's have no idea what AA/EPA is so there will be a learning curve"

Try 99%. I never heard of it until investing in AMRN. Doubt it's even covered by insurance?

However, the medical field is always looking for the best markers of CVD risk (LDL, HDL, CRP,BNP, LpPLA2, apo b, etc) and to see if changing these levels can change outcomes. It would be game changing if they proved the AA/EPA ratio was not only a solid biomarker of CVD but that Vascepa's reduction of it lead directly to improved outcomes.
If it ever was proven and accepted as an identifiable risk factor amenable to treatment that would be huge and possibly expanded coverage.

Some interesting articles by the AHA on biomarkers. None mention AA/EPA

https://www.ahajournals.org/doi/pdf/10.1161/JAHA.117.008108

https://www.ahajournals.org/doi/10.1161/CIR.0b013e31821c7c64

https://www.acc.org/latest-in-cardiology/articles/2018/04/02/14/47/cardiovascular-risk-assessment-in-older-adults-improved-with-biomarkers
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News